AIDS vaccine trial exceeds expectations
User rating: 4.3 / 5 after 3 vote(s)
An experimental AIDS vaccine of Merck & Co. has exceeded expectations and led to a double enrollment in the trial to 3,000, researchers said.
Full story »
|
An experimental AIDS vaccine of Merck & Co. has exceeded expectations and led to a double enrollment in the trial to 3,000, researchers said.
|